In 2014, which vaccination rate was lowest among adolescents 13 through 17 years of age?

The vaccination rate for the HPV vaccine among adolescents aged 13 through 17 years was the lowest in 2014 due to several factors. The HPV vaccine, which is designed to protect against human papillomavirus infections that can lead to cervical cancer and other cancers, has historically faced challenges in public acceptance and awareness.

Efforts to promote the vaccine have been complicated by misconceptions regarding the necessity of the vaccine, societal stigma, and discussions about sexual health that may deter parents from vaccinating their children. Additionally, while many adolescents receive vaccines like Tdap (tetanus, diphtheria, and pertussis) or meningococcal vaccines as part of routine immunization schedules typically recommended by healthcare providers, the HPV vaccine is often presented in discussions about sexual health, which may lead to parents deferring or opting out of the vaccine for their children.

In contrast, other vaccinations, such as the influenza vaccine and Tdap, are often more readily recommended and accepted by parents in routine pediatric care, contributing to higher immunization rates. The meningococcal vaccine has also been integrated into school immunization requirements, further boosting its uptake compared to the HPV vaccine.